-
Something wrong with this record ?
Profiling donepezil template into multipotent hybrids with antioxidant properties
E. Mezeiova, K. Spilovska, E. Nepovimova, L. Gorecki, O. Soukup, R. Dolezal, D. Malinak, J. Janockova, D. Jun, K. Kuca, J. Korabecny,
Language English Country England, Great Britain
Document type Journal Article, Review
Grant support
NV15-30954A
MZ0
CEP Register
Digital library NLK
Full text - Article
Source
NLK
Directory of Open Access Journals
from 2017
PubMed Central
from 2017
Europe PubMed Central
from 2017 to 2020
Taylor & Francis Open Access
from 2002-01-01
Medline Complete (EBSCOhost)
from 2007-02-01
- MeSH
- Acetylcholinesterase metabolism MeSH
- Alzheimer Disease drug therapy metabolism MeSH
- Antioxidants chemistry pharmacology MeSH
- Cholinesterase Inhibitors chemistry pharmacology MeSH
- Indans chemistry pharmacology MeSH
- Humans MeSH
- Molecular Structure MeSH
- Piperidines chemistry pharmacology MeSH
- Structure-Activity Relationship MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
Alzheimer's disease is debilitating neurodegenerative disorder in the elderly. Current therapy relies on administration of acetylcholinesterase inhibitors (AChEIs) -donepezil, rivastigmine, galantamine, and N-methyl-d-aspartate receptor antagonist memantine. However, their therapeutic effect is only short-term and stabilizes cognitive functions for up to 2 years. Given this drawback together with other pathological hallmarks of the disease taken into consideration, novel approaches have recently emerged to better cope with AD onset or its progression. One such strategy implies broadening the biological profile of AChEIs into so-called multi-target directed ligands (MTDLs). In this review article, we made comprehensive literature survey emphasising on donepezil template which was structurally converted into plethora of MTLDs preserving anti-cholinesterase effect and, at the same time, escalating the anti-oxidant potential, which was reported as a crucial role in the pathogenesis of the Alzheimer's disease.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18024309
- 003
- CZ-PrNML
- 005
- 20221014095330.0
- 007
- ta
- 008
- 180709s2018 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1080/14756366.2018.1443326 $2 doi
- 035 __
- $a (PubMed)29529892
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Mezeiová, Eva $u a Biomedical Research Centre, University Hospital Hradec Kralove , Hradec Kralove , Czech Republic. b National Institute of Mental Health , Klecany , Czech Republic. $7 xx0277560
- 245 10
- $a Profiling donepezil template into multipotent hybrids with antioxidant properties / $c E. Mezeiova, K. Spilovska, E. Nepovimova, L. Gorecki, O. Soukup, R. Dolezal, D. Malinak, J. Janockova, D. Jun, K. Kuca, J. Korabecny,
- 520 9_
- $a Alzheimer's disease is debilitating neurodegenerative disorder in the elderly. Current therapy relies on administration of acetylcholinesterase inhibitors (AChEIs) -donepezil, rivastigmine, galantamine, and N-methyl-d-aspartate receptor antagonist memantine. However, their therapeutic effect is only short-term and stabilizes cognitive functions for up to 2 years. Given this drawback together with other pathological hallmarks of the disease taken into consideration, novel approaches have recently emerged to better cope with AD onset or its progression. One such strategy implies broadening the biological profile of AChEIs into so-called multi-target directed ligands (MTDLs). In this review article, we made comprehensive literature survey emphasising on donepezil template which was structurally converted into plethora of MTLDs preserving anti-cholinesterase effect and, at the same time, escalating the anti-oxidant potential, which was reported as a crucial role in the pathogenesis of the Alzheimer's disease.
- 650 _2
- $a acetylcholinesterasa $x metabolismus $7 D000110
- 650 _2
- $a Alzheimerova nemoc $x farmakoterapie $x metabolismus $7 D000544
- 650 _2
- $a antioxidancia $x chemie $x farmakologie $7 D000975
- 650 _2
- $a cholinesterasové inhibitory $x chemie $x farmakologie $7 D002800
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a indany $x chemie $x farmakologie $7 D007189
- 650 _2
- $a molekulární struktura $7 D015394
- 650 _2
- $a piperidiny $x chemie $x farmakologie $7 D010880
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Spilovska, Katarina $u a Biomedical Research Centre, University Hospital Hradec Kralove , Hradec Kralove , Czech Republic. b National Institute of Mental Health , Klecany , Czech Republic. d Department of Chemistry , University of Hradec Kralove , Hradec Kralove , Czech Republic.
- 700 1_
- $a Nepovimova, Eugenie $u a Biomedical Research Centre, University Hospital Hradec Kralove , Hradec Kralove , Czech Republic. c Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences , Hradec Kralove , Czech Republic. d Department of Chemistry , University of Hradec Kralove , Hradec Kralove , Czech Republic.
- 700 1_
- $a Górecki, Lukáš $7 xx0243228 $u a Biomedical Research Centre, University Hospital Hradec Kralove , Hradec Kralove , Czech Republic. c Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences , Hradec Kralove , Czech Republic.
- 700 1_
- $a Soukup, Ondrej $u a Biomedical Research Centre, University Hospital Hradec Kralove , Hradec Kralove , Czech Republic. b National Institute of Mental Health , Klecany , Czech Republic.
- 700 1_
- $a Dolezal, Rafael $u a Biomedical Research Centre, University Hospital Hradec Kralove , Hradec Kralove , Czech Republic.
- 700 1_
- $a Malinak, David $u a Biomedical Research Centre, University Hospital Hradec Kralove , Hradec Kralove , Czech Republic. d Department of Chemistry , University of Hradec Kralove , Hradec Kralove , Czech Republic.
- 700 1_
- $a Janockova, Jana $u a Biomedical Research Centre, University Hospital Hradec Kralove , Hradec Kralove , Czech Republic.
- 700 1_
- $a Jun, Daniel $u a Biomedical Research Centre, University Hospital Hradec Kralove , Hradec Kralove , Czech Republic. c Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences , Hradec Kralove , Czech Republic.
- 700 1_
- $a Kuca, Kamil $u a Biomedical Research Centre, University Hospital Hradec Kralove , Hradec Kralove , Czech Republic. d Department of Chemistry , University of Hradec Kralove , Hradec Kralove , Czech Republic.
- 700 1_
- $a Korabecny, Jan $u a Biomedical Research Centre, University Hospital Hradec Kralove , Hradec Kralove , Czech Republic. c Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences , Hradec Kralove , Czech Republic.
- 773 0_
- $w MED00008009 $t Journal of enzyme inhibition and medicinal chemistry $x 1475-6374 $g Roč. 33, č. 1 (2018), s. 583-606
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29529892 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180709 $b ABA008
- 991 __
- $a 20221014095323 $b ABA008
- 999 __
- $a ok $b bmc $g 1316440 $s 1021230
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 33 $c 1 $d 583-606 $i 1475-6374 $m Journal of enzyme inhibition and medicinal chemistry $n J Enzyme Inhib Med Chem $x MED00008009
- GRA __
- $a NV15-30954A $p MZ0
- LZP __
- $a Pubmed-20180709